Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 8, 2013
Oxaliplatin-induced lung injury with allergic reactionTetsuya Homma, Masatsugu Kurokawa, Yoshitaka Yamamoto, et al.
Arthritis and Rheumatism|June 4, 2005
Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestationsNobuyuki Yajima, Tsuyoshi Kasama, Takeo Isozaki, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 1, 2009
Comparison of physicians' compliance, clinical efficacy, and drug cost before and after introduction of Asthma Prevention and Management Guidelines in Japan (JGL2003)Tomoko Suzuki, Michiko Kaneko, Isao Saito, et al.
Cancer Chemotherapy and Pharmacology|February 3, 2007
Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancerTakashi Hirose, Takao Shirai, Hiroo Ishida, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|June 22, 2011
[A case of pulmonary aspergilloma concomitant with allergic bronchopulmonary aspergillosis]Sojiro Kusumoto, Akihiko Tanaka, Shin Ohta, et al.
The Journal of Allergy and Clinical Immunology|August 19, 2004
Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL-17F), via Raf I-MEK-ERK pathwayMio Kawaguchi, Fumio Kokubu, Miho Odaka, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2004
Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveysKlaus F Rabe, Mitsuru Adachi, Christopher K W Lai, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 4, 2004
[Clinical pathway based on evidence-based medicine (EBM) for chemotherapy for lung cancer]Mari Kogo, Yumi Saito, Yuka Kashiwabara, et al.
Pageof 17